In focus
Latest feed
AstraZeneca's Texas Tangle: Unpacking the Kickback Settlement
AstraZeneca’s CEO Says AI Is Redefining How New Medicines Are Built
UK Researchers Adapt COVID‑19 Vaccine Platform to Tackle New Ebola Outbreak
AstraZeneca's Ultomiris Poised for Accelerated Approval in IgA Nephropathy After Striking Trial Results